ResMed (RMD) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $183.65 -0.31%
EPS Growth %: +14.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
CP, RUSHA, SEIC, More
EPS Growth %: +14.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.49, $0.04 better than the analyst estimate of $1.45. Revenue for the quarter came in at $914.7 million versus the consensus estimate of $910.54 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- FirstService (FSV) Tops Q2 EPS by 1c
- Biogen (BIIB) tops earnings expectations but revenue falls short
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
